Literature DB >> 34045693

The why behind the high: determinants of neurocognition during acute cannabis exposure.

Johannes G Ramaekers1, Natasha L Mason2, Lilian Kloft2, Eef L Theunissen2.   

Abstract

Acute cannabis intoxication may induce neurocognitive impairment and is a possible cause of human error, injury and psychological distress. One of the major concerns raised about increasing cannabis legalization and the therapeutic use of cannabis is that it will increase cannabis-related harm. However, the impairing effect of cannabis during intoxication varies among individuals and may not occur in all users. There is evidence that the neurocognitive response to acute cannabis exposure is driven by changes in the activity of the mesocorticolimbic and salience networks, can be exacerbated or mitigated by biological and pharmacological factors, varies with product formulations and frequency of use and can differ between recreational and therapeutic use. It is argued that these determinants of the cannabis-induced neurocognitive state should be taken into account when defining and evaluating levels of cannabis impairment in the legal arena, when prescribing cannabis in therapeutic settings and when informing society about the safe and responsible use of cannabis.

Entities:  

Year:  2021        PMID: 34045693     DOI: 10.1038/s41583-021-00466-4

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  213 in total

1.  Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States.

Authors:  Mahmoud A ElSohly; Zlatko Mehmedic; Susan Foster; Chandrani Gon; Suman Chandra; James C Church
Journal:  Biol Psychiatry       Date:  2016-01-19       Impact factor: 13.382

Review 2.  Understanding and learning from the diversification of cannabis supply laws.

Authors:  Beau Kilmer; Rosalie Liccardo Pacula
Journal:  Addiction       Date:  2016-11-27       Impact factor: 6.526

Review 3.  The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.

Authors:  Donald I Abrams
Journal:  Eur J Intern Med       Date:  2018-01-09       Impact factor: 4.487

Review 4.  Evaluating the public health impacts of legalizing recreational cannabis use in the United States.

Authors:  Wayne Hall; Michael Lynskey
Journal:  Addiction       Date:  2016-06-07       Impact factor: 6.526

5.  High-potency marijuana impairs executive function and inhibitory motor control.

Authors:  Johannes G Ramaekers; Gerhold Kauert; Peter van Ruitenbeek; Eef L Theunissen; Erhard Schneider; Manfred R Moeller
Journal:  Neuropsychopharmacology       Date:  2006-03-29       Impact factor: 7.853

Review 6.  Changing landscape of cannabis: novel products, formulations, and methods of administration.

Authors:  Tory R Spindle; Marcel O Bonn-Miller; Ryan Vandrey
Journal:  Curr Opin Psychol       Date:  2019-04-09

Review 7.  Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.

Authors:  Deborah S Hasin; Dvora Shmulewitz; Aaron L Sarvet
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-14       Impact factor: 3.829

8.  Mapping cannabis potency in medical and recreational programs in the United States.

Authors:  Mary Catherine Cash; Katharine Cunnane; Chuyin Fan; E Alfonso Romero-Sandoval
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

9.  Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile.

Authors:  Wendy Swift; Alex Wong; Kong M Li; Jonathon C Arnold; Iain S McGregor
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

10.  Increasing potency and price of cannabis in Europe, 2006-16.

Authors:  Tom P Freeman; Teodora Groshkova; Andrew Cunningham; Roumen Sedefov; Paul Griffiths; Michael T Lynskey
Journal:  Addiction       Date:  2019-01-16       Impact factor: 6.526

View more
  6 in total

Review 1.  Is resting-state functional connectivity altered in regular cannabis users? A systematic review of the literature.

Authors:  Hannah Thomson; Izelle Labuschagne; Lisa-Marie Greenwood; Emily Robinson; Hannah Sehl; Chao Suo; Valentina Lorenzetti
Journal:  Psychopharmacology (Berl)       Date:  2021-08-20       Impact factor: 4.530

2.  Decriminalization of marijuana opens doors for some scientists.

Authors:  Chris Woolston
Journal:  Nature       Date:  2022-08       Impact factor: 69.504

3.  Functional brain connectomes reflect acute and chronic cannabis use.

Authors:  J G Ramaekers; N L Mason; S W Toennes; E L Theunissen; E Amico
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

4.  Cannabis Use and Neuroadaptation: A Call for Δ 9 -Tetrahydrocannabinol Challenge Studies.

Authors:  Johannes G Ramaekers; Eef L Theunissen; Peter van Ruitenbeek; Natasha L Mason
Journal:  Front Psychiatry       Date:  2022-04-14       Impact factor: 5.435

5.  A cross-sectional survey: Exploring future healthcare workers' intention to use cannabis through extended theory of planned behavior.

Authors:  Sze Wing Cherelle Ho; Yuen Lung Wong; Pui Hong Chung
Journal:  Front Public Health       Date:  2022-08-22

6.  Machine Learning-Based Quantification of (-)-trans-Δ-Tetrahydrocannabinol from Human Saliva Samples on a Smartphone-Based Paper Microfluidic Platform.

Authors:  Yan Liang; Avory Zhou; Jeong-Yeol Yoon
Journal:  ACS Omega       Date:  2022-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.